>6 months at -80°C.
1. Li S. et al., Neurology. 41(2), 112-6 (2010).2. Strausberg, R.L. et al., Proc. Natl. Acad. Sci. U.S.A. 99 (26), 16899-16903 (2002).
1. Novel analogs targeting histone deacetylase suppress aggressive thyroid cancer cell growth and induce re-differentiation
2. Design, synthesis, 3D pharmacophore, QSAR, and docking studies of carboxylic acid derivatives as Histone Deacetylase inhibitors and cytotoxic agents
3. In Vivo Imaging of Histone Deacetylases (HDACs) in the Central Nervous System and Major Peripheral Organs (2014)
4. Kinetic method for the large-scale analysis of the binding mechanism of histone deacetylase inhibitors (2014)
5. Thermodynamics of ligand binding to histone deacetylase like amidohydrolase from Bordetella/Alcaligenes (2014)
6. A selective HDAC 1/2 inhibitor modulates chromatin and gene expression in brain and alters mouse behavior in two mood-related tests (2013)
7. Crebinostat: a novel cognitive enhancer that inhibits histone deacetylase activity and modulates chromatin-mediated neuroplasticity (2013)
8. Highly ligand efficient and selective N-2-(Thioethyl)picolinamide histone deacetylase inhibitors inspired by the natural product psammaplin A (2013)
9. Potent histone deacetylase inhibitors derived from 4-(aminomethyl)-N-hydroxybenzamide with high selectivity for the HDAC6 isoform (2013)
10. Santacruzamate A, a potent and selective histone deacetylase inhibitor from the Panamanian marine cyanobacterium cf. Symploca sp (2013)
11. Thioester derivatives of the natural product psammaplin A as potent histone deacetylase inhibitors (2013)
• HDAC Screening and Profiling
• Custom Protein
• Custom Cell Line Development
• Antibody Development
• Molecular and Cell Biology
Our products are for research use only, not for diagnostic or therapeutic use
Pricing is for US customers only. For other countries, please contact your local distributor.
© 2006 - 2017 BPS Bioscience, Inc. All Rights Reserved.
Connect With Us